Lack of association between circulating levels of plasma oxidized low-density lipoproteins and clinical outcome after coronary stenting.

[1]  G. Berglund,et al.  Plasma oxidized LDL: a predictor for acute myocardial infarction? , 2003, Journal of Internal Medicine.

[2]  Joseph Juliano,et al.  Temporal increases in plasma markers of oxidized low-density lipoprotein strongly reflect the presence of acute coronary syndromes. , 2003, Journal of the American College of Cardiology.

[3]  H. Horiguchi,et al.  Oxidized LDL in Carotid Plaques and Plasma Associates With Plaque Instability , 2002, Arteriosclerosis, thrombosis, and vascular biology.

[4]  A. Kastrati,et al.  Statin treatment following coronary artery stenting and one-year survival. , 2002, Journal of the American College of Cardiology.

[5]  K. Mann,et al.  Simvastatin Depresses Blood Clotting by Inhibiting Activation of Prothrombin, Factor V, and Factor XIII and by Enhancing Factor Va Inactivation , 2001, Circulation.

[6]  T. Matsuo,et al.  Elevated Levels of Oxidized Low Density Lipoprotein Show a Positive Relationship With the Severity of Acute Coronary Syndromes , 2001, Circulation.

[7]  J. Viikari,et al.  Oxidized LDL and thickness of carotid intima-media are associated with coronary atherosclerosis in middle-aged men: lower levels of oxidized LDL with statin therapy. , 2001, Atherosclerosis.

[8]  J. Ross,et al.  Improvement of coronary artery endothelial dysfunction with lipid-lowering therapy: heterogeneity of segmental response and correlation with plasma-oxidized low density lipoprotein. , 2001, Journal of the American College of Cardiology.

[9]  C. Glass,et al.  Mildly oxidized low density lipoprotein activates multiple apoptotic signaling pathways in human coronary cells , 2000, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[10]  M. Kurabayashi,et al.  Circulating Oxidized Low Density Lipoprotein Levels: A Biochemical Risk Marker for Coronary Heart Disease , 2000, Arteriosclerosis, thrombosis, and vascular biology.

[11]  P. Amouyel,et al.  Absence of relationship between plasma Lp(a), Lp-AI, anti-oxidized LDL autoantibodies, LDL immune complexes concentrations and restenosis after percutaneous transluminal coronary angioplasty. , 2000, Clinica chimica acta; international journal of clinical chemistry.

[12]  V. Fuster,et al.  Tissue characteristics of restenosis after percutaneous transluminal coronary angioplasty in diabetic patients. , 1999, Journal of the American College of Cardiology.

[13]  Y. Shoenfeld,et al.  Anti-oxidized low density lipoprotein antibody determination as a predictor of restenosis following percutaneous transluminal coronary angioplasty. , 1999, Immunology letters.

[14]  F. Werf,et al.  Malondialdehyde-modified LDL as a marker of acute coronary syndromes. , 1999, JAMA.

[15]  F. Werf,et al.  Oxidized LDL and malondialdehyde-modified LDL in patients with acute coronary syndromes and stable coronary artery disease. , 1998, Circulation.

[16]  M. Pfeffer,et al.  Inflammation, pravastatin, and the risk of coronary events after myocardial infarction in patients with average cholesterol levels. Cholesterol and Recurrent Events (CARE) Investigators. , 1998, Circulation.

[17]  U. Laufs,et al.  Upregulation of endothelial nitric oxide synthase by HMG CoA reductase inhibitors. , 1998, Circulation.

[18]  T. Lehtimäki,et al.  In vivo low density lipoprotein oxidation relates to coronary reactivity in young men. , 1997, Journal of the American College of Cardiology.

[19]  D. Steinberg,et al.  Lewis A. Conner Memorial Lecture. Oxidative modification of LDL and atherogenesis. , 1997, Circulation.

[20]  E. Lesaffre,et al.  Correlation between Oxidized Low Density Lipoproteins and von Willebrand Factor in Chronic Renal Failure , 1996, Thrombosis and Haemostasis.

[21]  M. Leon,et al.  Patterns and mechanisms of in-stent restenosis. A serial intravascular ultrasound study. , 1996, Circulation.

[22]  B. Björkerud,et al.  Contrary effects of lightly and strongly oxidized LDL with potent promotion of growth versus apoptosis on arterial smooth muscle cells, macrophages, and fibroblasts. , 1996, Arteriosclerosis, thrombosis, and vascular biology.

[23]  P. Edwards,et al.  Atherosclerosis: basic mechanisms. Oxidation, inflammation, and genetics. , 1995, Circulation.

[24]  U. de Faire,et al.  Patients with early-onset peripheral vascular disease have increased levels of autoantibodies against oxidized LDL. , 1995, Arteriosclerosis, thrombosis, and vascular biology.

[25]  G. Bellomo,et al.  LDL oxidation in patients with severe carotid atherosclerosis. A study of in vitro and in vivo oxidation markers. , 1994, Arteriosclerosis and thrombosis : a journal of vascular biology.

[26]  L. Hillis,et al.  Percutaneous transluminal coronary angioplasty. , 1994, The American journal of the medical sciences.

[27]  M. Gotsman,et al.  Plasma lipoproteins are not related to restenosis after successful coronary angioplasty. , 1993, The American journal of cardiology.

[28]  M. Naruszewicz,et al.  Simvastatin inhibits the oxidation of low-density lipoproteins by activated human monocyte-derived macrophages. , 1993, Biochimica et biophysica acta.

[29]  A. Hamsten,et al.  Susceptibility to low-density lipoprotein oxidation and coronary atherosclerosis in man , 1992, The Lancet.

[30]  J. Salonen,et al.  Autoantibody against oxidised LDL and progression of carotid atherosclerosis , 1992, The Lancet.

[31]  P. Shah,et al.  Low high density lipoprotein level is associated with increased restenosis rate after coronary angioplasty. , 1992, Circulation.

[32]  R. Pasternak,et al.  Effects of serum lipid levels on restenosis after coronary angioplasty. , 1991, The American journal of cardiology.

[33]  E J Topol,et al.  Coronary morphologic and clinical determinants of procedural outcome with angioplasty for multivessel coronary disease. Implications for patient selection. Multivessel Angioplasty Prognosis Study Group. , 1990, Circulation.

[34]  B. Meier,et al.  Serum lipoprotein levels fail to predict postangioplasty recurrent coronary artery stenosis. , 1989, Cleveland Clinic journal of medicine.

[35]  H. Itabe.  Oxidized low-density lipoproteins: what is understood and what remains to be clarified. , 2003, Biological & pharmaceutical bulletin.

[36]  D. Steinberg.  Oxidative Modification of LDL and Atherogenesis , 1998 .

[37]  W. Klein,et al.  Autoantibodies to oxidized low density lipoproteins in restenosis following coronary angioplasty. , 1994, Cardiology.

[38]  Charles L. Brown,et al.  Can restenosis after coronary angioplasty be predicted from clinical variables? , 1993, Journal of the American College of Cardiology.